Select a Sector or Industry
Gross Profit Margin Rankings for Biotechnology Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Gross Profit Margin
|
Pro Rating
|
|---|---|---|---|---|
| 1 | INCY | Incyte Corporation | 99.97% | Go Pro |
| 2 | AGEN | Agenus | 99.82% | Go Pro |
| 3 | HALO | Halozyme Therapeutics | 99.05% | Go Pro |
| 4 | CRIS | Curis | 98.90% | Go Pro |
| 5 | BDSI | BioDelivery Sciences International | 98.75% | Go Pro |
| 6 | IDIX | Idenix Pharmaceuticals | 96.72% | Go Pro |
| 7 | DYAX | Dyax | 95.32% | Go Pro |
| 8 | REGN | Regeneron Pharmaceuticals | 94.69% | Go Pro |
| 9 | CELG | Celgene Corporation | 94.30% | Go Pro |
| 10 | QCOR | Questcor Pharmaceuticals | 94.25% | Go Pro |
| 11 | SGEN | Seattle Genetics | 93.63% | Go Pro |
| 12 | VRTX | Vertex Pharmaceuticals | 91.06% | Go Pro |
| 13 | STEM | StemCells | 90.76% | Go Pro |
| 14 | IMMU | Immunomedics | 90.67% | Go Pro |
| 15 | JAZZ | Jazz Pharmaceuticals | 90.08% | Go Pro |
| 16 | BIIB | Biogen Idec | 89.69% | Go Pro |
| 17 | ALXN | Alexion Pharmaceuticals | 88.45% | Go Pro |
| 18 | SHPGY | Shire | 86.48% | Go Pro |
| 19 | SPPI | Spectrum Pharmaceuticals | 85.51% | Go Pro |
| 20 | BMRN | BioMarin Pharmaceutical | 85.34% | Go Pro |
| 21 | EBS | Emergent BioSolutions | 85.07% | Go Pro |
| 22 | GTXI | GTx | 85.02% | Go Pro |
| 23 | QLTI | QLT | 84.88% | Go Pro |
| 24 | OPTR | Optimer Pharmaceuticals | 84.12% | Go Pro |
| 25 | AMGN | Amgen | 83.23% | Go Pro |
| 26 | ACOR | Acorda Therapeutics | 82.28% | Go Pro |
| 27 | NKBP | China Nuokang Bio - Pharmaceutical | 81.34% | Go Pro |
| 28 | OMPI | Obagi Medical Products | 79.73% | Go Pro |
| 29 | VICL | Vical | 78.43% | Go Pro |
| 30 | AMLN | Amylin Pharmaceuticals | 77.51% | Go Pro |
| 31 | VPHM | ViroPharma | 76.38% | Go Pro |
| 32 | GILD | Gilead Sciences | 74.55% | Go Pro |
| 33 | CXM | Cardium Therapeutics | 73.17% | Go Pro |
| 34 | ARRY | Array BioPharma | 72.32% | Go Pro |
| 35 | CBPO | China Biologic Products | 70.77% | Go Pro |
| 36 | ITMN | InterMune | 67.70% | Go Pro |
| 37 | ILMN | Illumina | 66.36% | Go Pro |
| 38 | OSIR | Osiris Therapeutics | 65.96% | Go Pro |
| 39 | PLX | Protalix BioTherapeutics | 64.59% | Go Pro |
| 40 | ARNA | Arena Pharmaceuticals | 63.86% | Go Pro |
| 41 | SVA | Sinovac Biotech | 61.97% | Go Pro |
| 42 | CBP | China Botanic Pharmaceutical | 61.58% | Go Pro |
| 43 | CDXS | Codexis | 60.95% | Go Pro |
| 44 | CRTX | Cornerstone Therapeutics | 60.80% | Go Pro |
| 45 | RGEN | Repligen Corporation | 57.20% | Go Pro |
| 46 | SNTS | Santarus | 56.84% | Go Pro |
| 47 | ANIK | Anika Therapeutics | 55.34% | Go Pro |
| 48 | NEPT | Neptune Technologies & Bioresources | 53.00% | Go Pro |
| 49 | NKTR | Nektar Therapeutics | 51.49% | Go Pro |
| 50 | SVNT | Savient Pharmaceuticals | 51.33% | Go Pro |
